Guidelines on preventing cardiovascular disease in clinical practice.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis.The lancet. Diabetes & endocrinology · 2023
   Pooled it
2. Randomised trial assessing the impact of framing of fracture risk and osteoporosis treatment benefits in patients undergoing bone densitometry.BMJ open · 2017
   Trial
3. A multifaceted quality improvement intervention for CVD risk management in Australian primary healthcare: a protocol for a process evaluation.Implementation science : IS · 2014
   Trial
4. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).Clinical trials (London, England) · 2014
   Trial
5. First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation.Cardiovascular diabetology · 2008
   Trial
6. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial.Annals of family medicine
   Trial
7. Multivariate Sequential Analytics for Cardiovascular Disease Event Prediction.Methods of information in medicine · 2022
   Article
8. Actionable absolute risk prediction of atherosclerotic cardiovascular disease based on the UK Biobank.PloS one · 2022
   Article
9. Ten-year risk of fatal cardiovascular disease and its association with metabolic risk factors among waste pickers in South Africa.BMC cardiovascular disorders · 2021
   Article
10. Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning methods: a large population-based cohort study and external validation.BMC medical research methodology · 2021
    Article
11. iCARE: An R package to build, validate and apply absolute risk models.PloS one · 2020
    Article
12. A 10-Year Risk of Cardiovascular Disease among Patients with Severe Mental Illness at Mbarara Regional Referral Hospital, Southwestern Uganda.BioMed research international · 2020
    Article
13. Could chronic Vardenafil administration influence the cardiovascular risk in men with type 2 diabetes mellitus?PloS one · 2018
    Article
14. Impact of Sustained Use of a Multifaceted Computerized Quality Improvement Intervention for Cardiovascular Disease Management in Australian Primary Health Care.Journal of the American Heart Association · 2017
    Observational
15. Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis.Rheumatology (Oxford, England) · 2017
    Article
16. Predictors and patterns of problematic Internet game use using a decision tree model.Journal of behavioral addictions · 2016
    Article
17. Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America.Global heart · 2016
    Article
18. Predicting 10-Year Risk of Fatal Cardiovascular Disease in Germany: An Update Based on the SCORE-Deutschland Risk Charts.PloS one · 2016
    Article
19. Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population.Diabetes & metabolism journal · 2015
    Article
20. Predicting melanoma risk: theory, practice and future challenges.Melanoma management · 2014
    Review

Corrections and comments

• Commented on by
  Risk in cardiovascular disease. Merit of using risk reduction rather than absolute risk for lipid lowering drugs.2000
• Commented on by
  National service framework's financial implications are huge.2000
• Comment on
  Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?2000
• Comment on
  Estimating cardiovascular risk for primary prevention: outstanding questions for primary care.2000
• Comment on
  Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.2000
• Comment on
  Updated New Zealand cardiovascular disease risk-benefit prediction guide.2000
• Comment on
  Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association.2000
• Comment on
  Using the Framingham model to predict heart disease in the United Kingdom: retrospective study.2000

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as